IQVIA director granted 195 deferred shares
Fasano Jim reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Fasano Jim reported acquisition or exercise transactions in this Form 4 filing.
IQVIA Holdings Inc. director Jim Fasano received a grant of 195 deferred shares on July 14, 2026, at $207.83 per share. Each deferred share is convertible into one share of common stock upon settlement under the Non-Employee Director Deferral Plan, when he ceases to be a director, upon a change in control, or upon death, and there is no expiry date. Following this award, Fasano holds 6,268 deferred shares directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Shares F1 | 195 | $207.83 | $41K |
Footnotes (1)
- F1. Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.
Key Figures
Key Terms
Non-Employee Director Deferral Plan financial
change in control regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IQV (IQVIA Holdings Inc.) director Jim Fasano report?
Is Jim Fasano’s IQV transaction a market purchase or a grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.